Get In Touch

Sirolimus-eluting Stents Market: Introduction

  • Drug eluting stents are thin tubes with meshes coated with polymer that emit drug over a period to prevent scar tissue growth in the lining of the artery. These stents ensure the artery is open and smooth flow of blood across the heart. Sirolimus is a macrolide compound used in coronary stents to prevent organ transplant rejection and treat lymphangioleiomyomatosis, a rare lung disease.

Sirolimus-eluting Stents Market: Key Trends

  • Growth of the global sirolimus-eluting stents market can be ascribed to rise in prevalence of artery diseases and increase in the geriatric population. Additionally, surge in number of cardiac procedures in hospitals & ambulatory care centers and rise in awareness about the treatment options for cardiovascular diseases fuel the growth of the global sirolimus-eluting stents market. Reduction of in-stent restenosis with drug eluting stents vis-à-vis bare metal stents, rise in adoption of minimally invasive procedures, and increase in number of research studies on the usage of sirolimus-eluting stents provide lucrative opportunities in the market.
  • The world is presently struggling with the COVID-19 pandemic. COVID-19 leads to pneumonia, severe & acute respiratory disorders, multiple organ failure, and, in severe cases, death. The geriatric population is more prone to COVID-19. Growth of the global sirolimus-eluting stents market has been slightly hampered by the pandemic.
  • Governments of developing countries are making significant investments to modernize health care infrastructure in their respective countries, which is likely to increase access to health care. This is expected to increase the demand for sirolimus-eluting stents. Rise in prevalence of chronic heart diseases, especially heart attack, in developing countries presents lucrative opportunities in the global sirolimus-eluting stents market.

North America to Capture Major Share of Global Sirolimus-eluting Stents Market

  • North America is projected to account for large share of the global sirolimus-eluting stents market during the forecast period owing to the presence of key companies offering cardiac medical devices, technological advancements, and increase in number of cardiac implantations in health care centers. Prevalence of coronary heart disease (CHD) is rising among men and women in North America. According to the Centers for Disease Control and Prevention (CDC), nearly 655,000 people in the U.S. succumb to heart diseases in the U.S. each year. Additionally, heart disease is the leading cause of death among men, women, and people of racial and ethnic groups in the country. Moreover, one person dies every 36 seconds in the U.S. from cardiovascular disease.
  • The sirolimus-eluting stents market in Europe is likely to expand at a rapid pace during the forecast period, led by the rise in demand for drug eluting stents vis-à-vis bare metal stents, changing lifestyle, and rise in prevalence of lifestyle diseases such as diabetes and obesity in the region. The sirolimus-eluting stents market in Asia Pacific is expected to expand at a high CAGR during the forecast period driven by significant increase in number of cardiac procedures in countries such as China and India, rapid adoption of medical technologies, and surge in number of patients suffering from cardiac diseases, obesity, and diabetes. Furthermore, presence of well-qualified and experienced cardiac surgeons in hospitals, strengthening health care system, and increase in number of health care institutes offering education on drug delivery systems in cardiology are likely to boost the growth the sirolimus-eluting stents market in Asia Pacific during the forecast period. 

Key Players Operating in Global Sirolimus-eluting Stents Market

The global sirolimus-eluting stents market is highly consolidated due to the presence of small number of key players. These players hold major share in their respective regions. Growth strategies adopted by leading players are likely to drive the global sirolimus-eluting stents market.

Major players operating in the global sirolimus-eluting stents market are listed below:

  • iVascular S.L.U.
  • Nano Therapeutics Pvt. Ltd.
  • S3V Vascular Technologies
  • Meril Life Sciences Pvt. Ltd.
  • SMT
  • Eurocor Tech GmbH
  • Other prominent players

Global Sirolimus-eluting Stents Market: Research Scope

Global Sirolimus-eluting Stents Market, by Type

  • Polymer-based
  • Polymer-free

Global Sirolimus-eluting Stents Market, by End-user

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Global Sirolimus-eluting Stents Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Sirolimuseluting Stents Market